Experts In Vasectomy and Urological Treatments

Dr. Snoy is a general urologist. In addition to vasectomies he also treats:
• Bladder control
• Overactive bladder
• Bladder cancer
• Urinary incontinence
• Kidney stones
• Prostate disorders
• Prostate cancer
• Erectile dysfunction

Welcome to Urology Group of New Mexico - Vasectomy and Urology Experts

The Urology Group of New Mexico is dedicated to serving the urological needs of adults and children in the Albuquerque, NM, area. Our urologist, Dr. Frederick Snoy, is committed to providing quality urological care in a patient-friendly setting. Dr. Snoy has performed over 2,000 vasectomies making UGNM a premier vasectomy clinic. We offer vasectomy services using the modern “no scalpel” technique.

Experience has taught our practice to treat each patient as a partner in his or her medical care. Because some urological conditions are accompanied by discomfort or embarrassment, we emphasize sensitivity and discretion with all patients concerns.

Dr. Snoy is pleased to offer a variety of payment options including cash, credit card, cashier’s check and several flexible financing choices (including interest free) through CareCredit. Click the Care Credit logo to learn more or to apply.


logo-cc1

Urology Group of New Mexico is located at 4161 Montgomery Blvd, NE. (505) 872-4091

Testimonial - Steve's Story


Steve was diagnosed with kidney cancer. Dr. Snoy from Urology Group of New Mexico diagnosed the cancer and performed the surgical removal.

 
AccumetRx, a division of Urology Group of New Mexico will be participating in a new clinical trial. For more information about the study, contact David Waid, 505-872-4091 ext. 118, dwaid@accumetrx.com.

 

Study: Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency

Sponsor: NovaBay Pharmaceuticals, Inc.

 

Purpose:

Long-term indwelling urinary catheters are associated with chronic recurrent urinary tract infections and blockage caused by crystalline biofilm accumulation (encrustation) of the catheter surfaces. When the urine and catheter are colonized by urease-producing bacteria such as Proteus mirabilis, encrustation of the catheter is likely to occur.

The use of a catheter irrigation solution that can prevent biofilm formation and encrustation leading to blockage may keep the catheter patent longer, resulting in fewer catheter changes, potentially lower incidence of UTIs and better patient quality of life.

Auriclosene is a non-antibiotic, fast-acting, broad-spectrum antimicrobial, which exhibits potential for the rapid decolonization of a range of urologic pathogens, including the urease-producing Proteus mirabilis.

Subjects will be randomized to either Auriclosene Irrigation Solution or Auriclosene Vehicle solution.

 

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: A Multicenter, Randomized, Double-Blind, Efficacy Study of Auriclosene Irrigation Solution on Indwelling Urinary Catheter Patency

 

Eligibility

  • Ages Eligible for Study:
  • 18 Years and older
  • Genders Eligible for Study:
  • Both
  • Accepts Healthy Volunteers:
  • No

 

Criteria

 

Inclusion Criteria:

  • Subject requiring an indwelling urinary catheter with a history of catheter blockage and/or encrustation
  • Screening within 30 days of randomization
  • Exclusion Criteria:
  • Systemic antibiotic use within 14 days of first treatment
  • Investigational drug or device within 30 days if enrollment
  • Current infection requiring treatment with systemic antibiotics
  • Pregnant or lactating female
AccumetRx division of Urology Group of New Mexico
Albuquerque, New Mexico, United States, 87109
Contact: David Waid    505-872-4091 ext 118   dwaid@accumetrx.com